CLINICAL_TRIALS
trial_result
· 2017-05-31
Clinical Trial Update: Calcitonin for Treating X-linked Hypophosphatemia [NA]
Summary
A Yale University-sponsored clinical trial evaluating calcitonin for the treatment of X-linked hypophosphatemia has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Yale University | Conditions: Hypophosphatemic Rickets, X Linked Dominant | NA | Status: COMPLETED | Results posted: 2017-05-31